Telo Geonomics Announces Engagement of Investor Relations Service Provider

Core Insights - Telo Genomics Corp. has engaged Hayden IR, LLC to enhance its investor relations strategy and increase awareness of its technologies and business prospects [1][2] Group 1: Investor Relations Agreement - On August 20, 2025, Telo Genomics entered into a 12-month investor relations services agreement with Hayden, which includes strategic investor outreach and development of communication materials [2] - The company will pay Hayden a monthly fee of US$7,500, with US$3,500 of this fee accrued for the first four months, totaling US$14,000, payable upon the closing of Telo's next financing or by January 31, 2026 [2] - Either party can terminate the agreement with 30 days' written notice [2] Group 2: Company Overview - Telo Genomics is a biotech company specializing in a comprehensive telomere platform with applications in oncology and neurological diseases, focusing on liquid biopsies [4] - The company combines expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to develop accurate diagnostic products [4] - Telo Genomics has over 160 peer-reviewed publications and 30 clinical studies involving more than 3,000 patients, with its lead application, Telo-MM, aimed at improving treatment for Multiple Myeloma [4]